Delivery Order SPE2DB24D8003-SPE2DB25FJTWA
Award Date
2/21/25
Potential Completion Date
2/24/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $1,828.50 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4565765799 - MOUNJARO 10 MG/0.5 ML PEN 0.5ML. This contract award, identified as SPE2DB24FJTMQ, has an ultimate completion date of September 9, 2024. Dakota Drug, Inc. is a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the...
This federal contract award, valued at $2,694.90, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a delivery order for the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of August 30, 2024 and is structured as a firm fixed-price agreement. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84 and a period of performance through January 24, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,041.10, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period through January 2, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT...
This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) on December 13, 2024. The contract, valued at $2,360.58, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024 and is not set aside. Dakota Drug, Inc. is the prime contractor and does not have any major subcontractors listed. The contract is part of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,172.90 and a period of performance through October 18, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,566.52 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML. This award was made under contract SPE2DX24F7E3E, with a period of performance through June 24, 2024. Dakota Drug, Inc. is an experienced prime contractor that specializes in providing a wide range of pharmaceutical products, medical supplies, and...
This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,214.08, is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 22, 2024 and was awarded on May 21, 2024. Dakota Drug, Inc. has over two decades of experience providing a wide range of pharmaceutical products, medical...
This federal contract award, valued at $3,095.34, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, worth $999,999,999.00. The IDC falls under the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed-price, with a ceiling value of $2,468.66, and an ultimate completion date of November 5, 2024. This contract is not associated with a set-aside program. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract is part...